Cardiff Oncology, Inc. (CRDF)
0.998
+0.12
(+13.40%)
USD |
NASDAQ |
Aug 24, 16:00
0.9968
0.00 (0.00%)
After-Hours: 20:00
Cardiff Oncology Total Liabilities (Quarterly) : 10.80M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.80M |
| March 31, 2026 | 14.46M |
| December 31, 2025 | 16.50M |
| September 30, 2025 | 14.99M |
| June 30, 2025 | 17.13M |
| March 31, 2025 | 13.93M |
| December 31, 2024 | 14.24M |
| September 30, 2024 | 13.50M |
| June 30, 2024 | 13.66M |
| March 31, 2024 | 13.14M |
| December 31, 2023 | 11.90M |
| September 30, 2023 | 10.62M |
| June 30, 2023 | 10.88M |
| March 31, 2023 | 10.05M |
| December 31, 2022 | 9.848M |
| September 30, 2022 | 10.42M |
| June 30, 2022 | 10.79M |
| March 31, 2022 | 9.102M |
| December 31, 2021 | 9.127M |
| September 30, 2021 | 7.768M |
| June 30, 2021 | 4.816M |
| March 31, 2021 | 4.756M |
| December 31, 2020 | 6.570M |
| September 30, 2020 | 5.928M |
| June 30, 2020 | 5.745M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.672M |
| December 31, 2019 | 5.775M |
| September 30, 2019 | 5.266M |
| June 30, 2019 | 5.020M |
| March 31, 2019 | 4.847M |
| December 31, 2018 | 4.088M |
| September 30, 2018 | 3.941M |
| June 30, 2018 | 4.291M |
| March 31, 2018 | 5.729M |
| December 31, 2017 | 5.779M |
| September 30, 2017 | 8.273M |
| June 30, 2017 | 9.05M |
| March 31, 2017 | 23.24M |
| December 31, 2016 | 24.18M |
| September 30, 2016 | 26.23M |
| June 30, 2016 | 24.15M |
| March 31, 2016 | 24.85M |
| December 31, 2015 | 22.74M |
| September 30, 2015 | 22.16M |
| June 30, 2015 | 25.52M |
| March 31, 2015 | 22.27M |
| December 31, 2014 | 20.55M |
| September 30, 2014 | 20.41M |
| June 30, 2014 | 18.86M |
| March 31, 2014 | 6.706M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ocugen, Inc. | 140.76M |
| CytomX Therapeutics, Inc. | 79.16M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 37.33M |
| Shareholders Equity (Quarterly) | 26.53M |
| Debt to Equity Ratio | 0.0172 |
| Current Ratio | 3.296 |
| Net Debt Paydown Yield | 0.20% |